According to Global Blue Group's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.26996. At the end of 2023 the company had a P/S ratio of 2.16.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.16 | -32.34% |
2022 | 3.19 | -68.79% |
2021 | 10.2 | -40.29% |
2020 | 17.1 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 3.79 | 66.77% | ๐บ๐ธ USA |
Medtronic MDT | 3.28 | 44.32% | ๐ฎ๐ช Ireland |
Boston Scientific BSX | 7.56 | 232.84% | ๐บ๐ธ USA |
Edwards Lifesciences EW | 8.68 | 282.58% | ๐บ๐ธ USA |
Stryker Corporation SYK | 6.23 | 174.32% | ๐บ๐ธ USA |